Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis - Poll - MDSpire

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

  • By

  • Erha Munai

  • Lisi Sun

  • Amu Jike

  • Dan Tao

  • Nan Li

  • Jiang He

  • Yu He

  • Liang Du

  • Wei Zhou

  • Yongzhong Wu

  • Dingyi Yang

  • June 22, 2026

  • 0 min

Share

Original Source(s)

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

  • by Erha Munai, Lisi Sun, Amu Jike, Dan Tao, Nan Li, Jiang He, Yu He, Liang Du, Wei Zhou, Yongzhong Wu, Dingyi Yang

  • June 22, 2026

Related Content

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies

Virtual Staining and the Next Era of Pathology

How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research

The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment